Boston, MA -- (SBWire) -- 02/10/2014 --Signal Genetics LLC (Signal Genetics) is a commercial stage, molecular diagnostic company. The company provides diagnostic services that help the physicians to make better informed decisions relating to the care of their patients suffering from cancer. It follows MyPRS Plus testing methodology, which is a microarray-based gene expression profiling assay used to assist the management of patients with multiple myeloma and related disorders. Signal Genetics' research laboratory performs cell-sorting, isolation and gene expression profiling services for pharmaceutical and research organizations from across the country. The company has the ability to maximize patient sample potential and perform customizable data analysis to provide vital and rare data in the format that is mostly suited for the organizations. Signal Genetics is headquartered in New York, the US.
View Full Report Details and Table of Contents
This report is a source for data, analysis and actionable intelligence on the Signal Genetics LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Get This Report
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2013 Update
- Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2013 Update
- Innovia LLC - Product Pipeline Analysis, 2013 Update
- Advanced Bionics, LLC - Product Pipeline Analysis, 2013 Update
- Veridex, LLC - Product Pipeline Analysis, 2013 Update
- Atlas Genetics Ltd. - Product Pipeline Analysis, 2013 Update
- BioMarker Strategies, LLC - Product Pipeline Analysis, 2013 Update
- Pop Test LLC - Product Pipeline Analysis, 2013 Update
- Alfa Wassermann Diagnostic Technologies, LLC - Product Pipeline Analysis, 2013 Update
- AnalizaDx, LLC - Product Pipeline Analysis, 2013 Update
Market Report, "Signal Genetics LLC - Product Pipeline Analysis, 2013 Update", Published
New Medical Devices research report from GlobalData is now available from Fast Market Research